Morepen Laboratories Ltd. (MOREPENLAB): Morepen Laboratories Share Price Hits Fresh 52-Week High on NSE

Morepen Laboratories Share Price is trading at Rs 118.7, up 4.4% from the previous close of Rs 113.7, after touching a fresh 52-week high of Rs 119.55. The company’s market capitalisation stands at Rs 6,230.23 crore as of 07 September 2026 at 10:52 AM IST. The move places Morepen Laboratories Ltd. (MOREPENLAB) in focus for Morepen Laboratories Stock News and Morepen Laboratories Share Price Today searches because the latest Univest data confirms a new yearly high within the ongoing market session.

The price action is clear: the stock opened at Rs 116.35, moved between Rs 114.55 and Rs 119.55, and last traded at Rs 118.7. Turnover stood at Rs 7.63 crore. The latest Univest figures confirm the fresh 52-week high event, but they do not establish a company-specific catalyst. For readers tracking Morepen Laboratories Share Price Live, the key story today is the new yearly high itself, supported by a higher trading range and a market value above Rs 6,000 crore.

Morepen Laboratories Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 118.7
Previous Close	Rs 113.7
Today's Move	+Rs 5 (+4.4%)
Open	Rs 116.35
High	Rs 119.55
Low	Rs 114.55
Turnover	Rs 7.63 crore
Market Capitalisation	Rs 6,230.23 crore

Morepen Laboratories Ltd. (MOREPENLAB) traded at Rs 118.7 versus the previous close of Rs 113.7, a rise of 4.4%. The stock opened at Rs 116.35, reached a high of Rs 119.55 and touched a low of Rs 114.55.

Morepen Laboratories Share Price Today shows a gain of Rs 5 from the previous close, or 4.4%, with the stock last traded at Rs 118.7. The intraday high of Rs 119.55 exactly matches the 52-week high, while the low was Rs 114.55 and the open was Rs 116.35. Turnover of Rs 7.63 crore adds a factual scale point to the day’s activity.

Because the current price has reached a fresh 52-week peak, the breakout from the previous 52-week high of Rs 119.55 is not a gap-based move; it is the same level, reached during the session. That keeps the Morepen Laboratories Share Price Update firmly tied to a price milestone rather than a separate event narrative. On a news desk basis, Morepen Laboratories News Today is about the market confirming a yearly high in the ordinary course of trading, not about an unverified trigger.

For investors scanning Morepen Laboratories Stock Analysis and Morepen Laboratories Share News, the most relevant facts are the higher intraday range, the positive day change and the market capitalisation already embedded in the mid-thousands of crores. The next section places that valuation context alongside the healthcare sector and pharmaceutical peers.

Morepen Laboratories Ltd. (MOREPENLAB) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 6,230.23 crore
P/E Ratio	44.33x
P/B Ratio	4.78x
ROE	11.78%
ROCE	15.48%
EPS	Rs 2.56
Book Value Per Share	Rs 23.78
Dividend Yield	0.18%

Morepen Laboratories Ltd. (MOREPENLAB) fundamental metrics show P/E 44.33x, P/B 4.78x, ROE 11.78%, ROCE 15.48%. These figures provide context only and are not a buy or sell signal.

Morepen Laboratories Ltd. has a market capitalisation of Rs 6230.23 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 44.33x, P/B at 4.78x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.78% and ROCE of 15.48%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 2.56, book value per share of Rs 23.78, dividend yield of 0.18%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.47x, median ROE of 11.79%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	44.33x
Benchmark Median P/E	32.47x
Benchmark Average P/E	48.82x
Benchmark P/E Range	3.2x to 659.73x
Company P/B Ratio	4.78x
Benchmark Median P/B	2.89x
Company ROE	11.78%
Benchmark Median ROE	11.79%
Company ROCE	15.48%
Benchmark Median ROCE	13.63%
Company Market Capitalisation	Rs 6,230.23 crore
Benchmark Median Market Cap	Rs 673.68 crore

Morepen Laboratories Ltd. (MOREPENLAB) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Morepen Laboratories Ltd. (MOREPENLAB) has a P/E ratio of 44.33x, which is above the benchmark median of 32.47x, a difference of +36.53%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Morepen Laboratories Ltd. (MOREPENLAB) has a ROE of 11.78%, which is below the benchmark median of 11.79%, a difference of -0.08%. Morepen Laboratories Ltd. (MOREPENLAB) has a ROCE of 15.48%, which is above the benchmark median of 13.63%, a difference of +13.57%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
SENORES PHARMACEUTICALS L	SENORES	6,572.31	52.01	6.82	14.14	15.66
IOL Chemicals And Pharmaceuticals Ltd.	IOLCP	5,872.02	34.93	3.15	7.9	10.65
Innova Captab Ltd.	INNOVACAP	6,720.78	43	5.92	13.75	15.04
Orchid Pharma Ltd.	ORCHPHARMA	5,717.24	659.73	4.4	7.86	8.05
Supriya Lifescience Ltd.	SUPRIYA	6,882.89	34.7	5.63	19.06	25.3

Morepen Laboratories Ltd. (MOREPENLAB) has a P/E ratio of 44.33x compared with the displayed peer median of 43x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 11.78% compares with a peer median of 13.75% across the companies shown in the table. ROCE stood at 15.48% versus the displayed peer median of 15.04%, providing a capital-efficiency comparison. Morepen Laboratories Ltd. (MOREPENLAB) has a market capitalisation of Rs 6,230.23 crore. Among the 5 peers shown, 3 have a larger market capitalisation.

Why Investors Are Watching Morepen Laboratories

• Morepen Laboratories Share Price touched a fresh 52-week high of Rs 119.55 and last traded at Rs 118.7.
• The stock was up Rs 5, or 4.4%, versus the previous close of Rs 113.7.
• Turnover stood at Rs 7.63 crore during the ongoing session.
• Market capitalisation was Rs 6,230.23 crore at the latest update.
• P/E was 44.33, P/B was 4.78, ROE was 11.78% and ROCE was 15.48%.

About Morepen Laboratories

Morepen Laboratories Ltd. belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is identified on NSE and BSE as MOREPENLAB. Morepen Laboratories Share Price is therefore followed by readers who track healthcare names, valuation ratios and company-level market updates in a single place on Univest.

Frequently Asked Questions

What is Morepen Laboratories Share Price today?

Ans. Morepen Laboratories Share Price was last traded at Rs 118.7, up 4.4% from the previous close of Rs 113.7. The stock also touched a fresh 52-week high of Rs 119.55 during the session.

Why did Morepen Laboratories Share Price hit a fresh 52-week high?

Ans. The latest Univest data confirms the fresh 52-week high event, but it does not establish a company-specific catalyst. What is verified is the higher intraday range, the day gain and the new yearly peak.

What was Morepen Laboratories Share Price today’s range?

Ans. Morepen Laboratories Share Price moved between Rs 114.55 and Rs 119.55. The day opened at Rs 116.35 and the high matched the 52-week high, which makes the price action straightforward to track.

What is Morepen Laboratories market capitalisation?

Ans. Morepen Laboratories has a market capitalisation of Rs 6,230.23 crore. That places the company above the industry median market cap in the same-industry benchmark used in this article.

How is Morepen Laboratories valued on P/E and P/B?

Ans. Morepen Laboratories trades at a P/E of 44.33 and a P/B of 4.78. Both are above the same-industry median, which helps explain why valuation remains part of Morepen Laboratories Stock Analysis.

What do ROE and ROCE show for Morepen Laboratories?

Ans. ROE is 11.78% and ROCE is 15.48%. ROE is almost in line with the industry median, while ROCE is above both the median and average in the benchmark set.

What do EPS, book value and dividend yield mean here?

Ans. EPS is 2.56, book value is Rs 23.78 and dividend yield is 0.18%. EPS reflects earnings per share, book value shows accounting net worth per share and dividend yield reflects the current payout context.

How does Morepen Laboratories compare with peers?

Ans. Compared with peers such as SENORES, IOLCP, Innova Captab, Orchid Pharma and Supriya Lifescience, Morepen Laboratories sits in the middle on market cap and shows a mixed peer profile on valuation and returns.

Track Morepen Laboratories Share Price on Univest

Use Morepen Laboratories Ltd. (MOREPENLAB) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Track Morepen Laboratories Share Price on Univest for live share price updates, company news, market capitalisation, fundamental ratios, 52-week levels, and peer context. Readers can also check Morepen Laboratories Share Price Today, Morepen Laboratories Latest News, and Morepen Laboratories Stock News in one place through Univest.